Corbus Pharmaceuticals Holdings, Inc. (CRBP) financial statements (2023 and earlier)

Company profile

Business Address 500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments97,64785,43331,74941,74862,53714,99212,338
Cash and cash equivalents25,00785,43331,74941,74862,53714,99212,338
Short-term investments72,641      
Restricted cash and investments192350  159150 
Receivables     1,000 
Prepaid expense   2,492 930377
Other undisclosed current assets2,3656,2916,406 2,808330 
Total current assets:100,20592,07538,15544,24065,50517,40312,715
Noncurrent Assets
Operating lease, right-of-use asset4,6095,2495,819
Property, plant and equipment2,3934,0685,0842,7051,433435124
Restricted cash and investments477670   5036
Other noncurrent assets46234854441  
Total noncurrent assets:7,52610,22010,9882,7491,473485161
TOTAL ASSETS:107,730102,29549,14246,98966,97817,88812,875
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,87629,38733,53916,1977,8726,6761,877
Accounts payable1,7827,38111,0916,3453,1303,4201,314
Accrued liabilities10,09322,00522,4489,8514,7423,256562
Debt3,0937101,348394333272162
Deferred rent credit   36
Derivative instruments and hedges, liabilities134797     
Deferred revenue and credits 1,9501,591
Contract with customer, liability1,463
Other undisclosed current liabilities1,9051,004     
Total current liabilities:17,00831,89834,88818,0898,2058,8993,630
Noncurrent Liabilities
Long-term debt and lease obligation21,59225,1228,097    
Long-term debt, excluding current maturities15,63618,029     
Operating lease, liability5,9567,0938,097
Liabilities, other than long-term debt22  1,37699070260
Deferred revenue and credits99066260
Deferred rent credit   1,376
Other liabilities22   05 
Other undisclosed noncurrent liabilities (7,093)     
Total noncurrent liabilities:21,61525,1228,0971,37699070260
Total liabilities:38,62257,02042,98519,4659,1958,9693,890
Stockholders' equity
Stockholders' equity attributable to parent, including:69,10845,2756,15827,52457,7848,9198,985
Common stock131066644
Common stock, share subscribed but unissued, subscriptions receivable     (330) 
Additional paid in capital418,892349,358198,975148,889123,47642,19122,259
Accumulated other comprehensive loss(62)      
Accumulated deficit(349,734)(304,093)(192,824)(121,370)(65,698)(33,276)(13,278)
Other undisclosed stockholders' equity attributable to parent     330 
Total stockholders' equity:69,10845,2756,15827,52457,7848,9198,985
TOTAL LIABILITIES AND EQUITY:107,730102,29549,14246,98966,97817,88812,875

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues8823,93736,1444,8222,4401,911648
Gain (loss) on disposition of assets for financial service operations663(251)  
Gross profit:8823,93736,1444,8222,4401,911648
Operating expenses(56,871)(126,747)(113,248)(61,570)(35,003)(21,896)(9,502)
Operating loss:(55,989)(122,810)(77,105)(56,748)(32,563)(19,985)(8,854)
Nonoperating income (expense)10,34911,5415,6511,076141(14)3
Investment income, nonoperating  1,228   3
Foreign currency transaction gain (loss), before tax(384)(450)(159)93(42)(14)2
Other nonoperating income11,900 4,582    
Interest and debt expense(2,709)(1,127)  (1)(1)(2)
Loss before gain (loss) on sale of properties:(48,349)(112,396)(71,454)(55,672)(32,422)(20,000)(8,853)
Other undisclosed net income2,709      
Net loss:(45,640)(112,396)(71,454)(55,672)(32,422)(20,000)(8,853)
Other undisclosed net income attributable to parent 1,127  112
Net loss available to common stockholders, diluted:(45,640)(111,269)(71,454)(55,672)(32,422)(19,999)(8,851)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(45,640)(112,396)(71,454)(55,672)(32,422)(20,000)(8,853)
Other comprehensive loss(62)      
Comprehensive loss, net of tax, attributable to parent:(45,703)(112,396)(71,454)(55,672)(32,422)(20,000)(8,853)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: